We have previously developed a MCPyV transgenic mouse model (K14Cre-MCPyV168), in which expression of both truncated LT and intact ST, as expressed in MCC tumors, is directed to the skin using a keratin 14 (K14) promoter. This evidence concerns the gene KRT14 and Merkel cell skin cancer.